Sale!
Replica: Next-Gen EGFR-TKI for Ex19Del/L858R NSCLC w/ Cerebral Protection
Replica: Next-Gen EGFR-TKI for Ex19Del/L858R NSCLC w/ Cerebral Protection - Image 2

Replica: Next-Gen EGFR-TKI for Ex19Del/L858R NSCLC w/ Cerebral Protection

Original price was: $727.00.Current price is: $568.00.

Osimertinib targets EGFR mutations; 3rd-gen irreversible EGFR-TKI; treats central nervous system metastases; suitable for NSCLC with EGFR Ex19Del or L858R mutations,

SKU: SKU67E6P2KAR Category:
Contact via Email Contact via WhatsApp
Guaranteed Safe Checkout

Osimertinib targets EGFR mutations; 3rd-gen irreversible EGFR-TKI; treats central nervous system metastases; suitable for NSCLC with EGFR Ex19Del or L858R mutations,

Related products

Scroll to Top